Evidence map›Paper›PMID 32565274›Full record

ArticleInfectious diseases now2021

Evaluation of a web-based self-reporting method for monitoring international passengers returning from an area of emerging infection.

B Lefèvre, T Blanchon, P Saint-Martin, P Tattevin, D Che, E Caumes, T Pitel, L Rossignol, N Dournon, X Duval and 2 more

Abstract read
In one paragraph

Article in Infectious diseases now, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

B LefèvreService de maladies infectieuses et tropicales, hôpitaux de Brabois, centre régional hospitalier universitaire de Nancy, 54511 Vandœuvre-lès-Nancy cedex, France; Service de maladies infectieuses et tropicales, dermatologie, médecine interne, centre hospitalier universitaire de Pointe-à-Pitre, BP 465, 97159 Pointe-à-Pitre, France; EA 4360 APEMAC, faculté de médecine, université de Lorraine, avenue de la Forêt de Haye, 54500 Vandœuvre-lès-Nancy, France. Electronic address: b.lefevre@chru-nancy.fr.
T BlanchonInserm, institut Pierre-Louis d'épidémiologie et de santé publique (IPLESP UMRS 1136), Sorbonne universités, UPMC université Paris 06, 75012 Paris, France. Electronic address: thierry.blanchon@upmc.fr.
P Saint-MartinPôle de veille et sécurité sanitaires, Agence régionale de santé de Guadeloupe, Saint-Martin, Saint-Barthélemy, 97113 Goubeyre, France. Electronic address: patrick.saint-martin@ars.sante.fr.
P TattevinService maladies infectieuses et réanimation médicale, centre hospitalo-universitaire de Rennes, 2, rue Henri-Le-Guilloux, 35033 Rennes cedex, France. Electronic address: pierre.tattevin@chu-rennes.fr.
D CheDépartement des maladies infectieuses, santé publique France, 94415 Saint-Maurice cedex, France. Electronic address: didier.che@santepubliquefrance.fr.
E CaumesDépartement des maladies infectieuses et de médecine tropicale, hôpital La Pitié-Salpêtrière, Paris, France; Inserm, services des maladies infectieuses et tropicales, hôpital la Pitié-Salpêtrière, institut Pierre-Louis d'épidémiologie et de santé publique (IPLESP), Sorbonne université, AP-HP, 75571 Paris cedex 12, France. Electronic address: eric.caumes@aphp.fr.
T PitelInserm, institut Pierre-Louis d'épidémiologie et de santé publique (IPLESP UMRS 1136), Sorbonne universités, UPMC université Paris 06, 75012 Paris, France. Electronic address: thibaud.pitel@iplesp.upmc.fr.
L RossignolInserm, institut Pierre-Louis d'épidémiologie et de santé publique (IPLESP UMRS 1136), Sorbonne universités, UPMC université Paris 06, 75012 Paris, France. Electronic address: louise.rossignol@ipliesp.upmc.fr.
N DournonService de maladies infectieuses et tropicales, dermatologie, médecine interne, centre hospitalier universitaire de Pointe-à-Pitre, BP 465, 97159 Pointe-à-Pitre, France. Electronic address: nathalie.dournon@chu-guadeloupe.fr.
X DuvalHôpital Bichat-Claude-Bernard, AP-HP, Paris, France; Inserm CIC1425, Paris, France; IAME UMR 1138, 75877 Paris cedex 18, France. Electronic address: xavier.duval@aphp.fr.
B HoenService de maladies infectieuses et tropicales, hôpitaux de Brabois, centre régional hospitalier universitaire de Nancy, 54511 Vandœuvre-lès-Nancy cedex, France; Service de maladies infectieuses et tropicales, dermatologie, médecine interne, centre hospitalier universitaire de Pointe-à-Pitre, BP 465, 97159 Pointe-à-Pitre, France; EA 4360 APEMAC, faculté de médecine, université de Lorraine, avenue de la Forêt de Haye, 54500 Vandœuvre-lès-Nancy, France; Inserm, centre d'investigation clinique 1424, centre hospitalier universitaire de Pointe-à-Pitre, BP 465, 97159 Pointe-à-Pitre, France. Electronic address: bruno@hoen.pro.
SPILF-COREB Emergence group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesEmerging infectious diseases are a public health issue of international concern. Identifying methods to limit their expansion is essential. We assessed the feasibility of a screening strategy in which each traveler would actively participate in the screening process after an intercontinental flight by reporting their own health status via a web-based self-administered questionnaire. PATIENTS AND

methodsIn 2015 and 2017, we invited passengers arriving at or departing from Pointe-à-Pitre international airport to answer an online health questionnaire during the four days following their arrival from or at Paris-Orly international airport. SPIRE 1 was intended for passengers arriving at Pointe-à-Pitre and was conceived as a pilot study. SPIRE 2 was an improved version of SPIRE 1 and consisted in three parts, which permitted to further assess the benefits of pre-flight request and email follow-up. Endpoints were the connection rates and response rates to online health questionnaire.

resultsFor SPIRE 1, 4/1038 travelers (0.4%) completed the two steps of the online health questionnaire. In SPIRE 2, response rates ranged from 3/1059 (0.3%) to 19/819 (2.3%). Response rates were significantly better when passengers were approached before their flight.

conclusionsThe yield of an online health questionnaire was unexpectedly low.

Indexed as

InternetSelf ReportTravelAircraftCommunicable Diseases, EmergingFeasibility StudiesHealth StatusHumansMass ScreeningParisPilot ProjectsPublic HealthSurveys and QuestionnairesTravel MedicineEmerging infectious diseaseInternational travelers monitoringTraveler's healthTravel medicine

Identifiers

PMID32565274
PMCPMC7301833

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.